SILVER DIGITAL INNOVATION PARTNER

Roslin Technologies is a Scottish biotech company pioneering the application of cutting-edge stem cell and genomic technologies for a wide range of industries.

We aim to improve animal welfare through the use of our novel stem cell technology platform. Our proprietary platform produces induced pluripotent stem (iPS) cells for the Animal Therapy market – iPS cells can be turned into any type of cell found in the body, allowing them to be applied to tackle a range of illnesses such as cancer, arthritis, or diabetes.

We are world-leading experts on animal iPS cell development, with lines currently available or in development for a wide range of animals. As pioneers in animal iPS cell technology, the cell lines we have created will benefit the health and welfare of companion animals worldwide. We are currently looking for partners in the animal therapies space with an interest in utilising our Canine induced pluripotent stem cell lines.

MEET OUR TEAM

Richard Freeman, PhD Richard Freeman, PhD
Roslin Technologies Limited
Commercial Manager
Jacqui Matthews Jacqui Matthews
Roslin Technologies
Chief Scientific Officer
Ernst van Orsouw Ernst van Orsouw
Roslin Technologies
CEO

VIEW OUR USEFUL RESOURCES